Trademark: 97129203
Word
NORQUET
Status
Dead
Status Code
606
Status Date
Monday, July 3, 2023
Serial Number
97129203
Mark Type
4000
Filing Date
Wednesday, November 17, 2021
Published for Opposition
Tuesday, October 4, 2022
Abandoned Date
Monday, July 3, 2023

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Jul 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 3, 2023
Abandonment - No Use Statement Filed
Nov 29, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 4, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2022
Published For Opposition
Sep 14, 2022
Notification Of Notice Of Publication E-Mailed
Aug 30, 2022
Approved For Pub - Principal Register
Aug 25, 2022
Assigned To Examiner
Nov 22, 2021
New Application Office Supplied Data Entered
Nov 20, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24